NCT07447089Recruiting
EMDR Integrative Group Protocol and Individual Treatment for Patients With Cancer: A Pilot Study
Combination of the EMDR Integrative Group Protocol and Individual EMDR Treatment in Patients With Advanced Thyroid Cancer: A Pilot Study
Source: ClinicalTrials.gov · Last updated 4 Mar 2026
Brief summary (registry, in English)
The main aim of the present process-outcome study is to evaluate the feasibility and the effects of an EMDR-IGTP-OTS group intervention on a sample of people with cancer, by using a process-outcome study design, with repeated measures.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 25 (estimated)
- First submitted
- 25 Feb 2026
- Start date
- Dec 2025
- Primary completion date
- Oct 2026
- Lead sponsor
- Università Cattolica di Milano
- Diseases
- Thyroid cancer
- NCT number
- NCT07447089
What you commit to
- Study type: Interventional
- Planned participants: 25
- From Dec 2025 to the primary completion date, Oct 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- receiving specialized trauma therapy
- receiving current psychiatric pharmacological treatment, unless the dosage has been stable for at least 2 months prior to enrollment
Who the study is looking for
- cancer diagnosis
- PTSD (IES-R \> 32)
Age in the registry: 18 years to 100 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Università Cattolica del Sacro Cuore Coordinator of this site? Confirm its status | Milan | Italy | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.